By expenditures
| Name | Title | Type |
|---|---|---|
| Alicia Dillard | University | Auditee |
| Allan Smith | IT Consultant | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 367150 | 2024 | 2025-09-23 | Allan Smith & Company CPAS PC | $68.61M |
| 331629 | 2023 | 2024-12-10 | Allan Smith & Company CPAS PC | $64.87M |
| 323866 | 2022 | 2024-10-04 | Allan Smith & Company CPAS PC | $68.25M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 367150 | 2024 | 2025-09-23 | 1154235 | 2024-001 | Material Weakness | Yes | L |
| 367150 | 2024 | 2025-09-23 | 1154234 | 2024-001 | Material Weakness | Yes | L |
| 367150 | 2024 | 2025-09-23 | 1154233 | 2024-001 | Material Weakness | Yes | L |
| 367150 | 2024 | 2025-09-23 | 1154232 | 2024-001 | Material Weakness | Yes | L |
| 367150 | 2024 | 2025-09-23 | 1154231 | 2024-001 | Material Weakness | Yes | L |
| 367150 | 2024 | 2025-09-23 | 1154230 | 2024-001 | Material Weakness | Yes | L |
| 367150 | 2024 | 2025-09-23 | 1154229 | 2024-001 | Material Weakness | Yes | L |
| 367150 | 2024 | 2025-09-23 | 1154228 | 2024-001 | Material Weakness | Yes | L |
| 367150 | 2024 | 2025-09-23 | 1154227 | 2024-001 | Material Weakness | Yes | L |
| 367150 | 2024 | 2025-09-23 | 1154226 | 2024-001 | Material Weakness | Yes | L |
| 331629 | 2023 | 2024-12-10 | 1090179 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 1090178 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 1090177 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 1090176 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 1090175 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 1090174 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 1090173 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 1090172 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 1090171 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 1090170 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 1090169 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 513737 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 513736 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 513735 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 513734 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 513733 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 513732 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 513731 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 513730 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 513729 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 513728 | 2023-001 | Significant Deficiency | - | L |
| 331629 | 2023 | 2024-12-10 | 513727 | 2023-001 | Significant Deficiency | - | L |